drugset / Trial / NCT01228331

Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL

NCT01228331

Phase 2/3 Completed 745 enrolled University Medical Center Hamburg-Eppendorf
RandomizedParallel-groupOpen-labelTreatment

Summary

RATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than once drug (combination chemotherapy) may kill more cancer cells. Radiation therapy uses high-energy x-rays to kill cancer cells. It is not yet known whether giving clofarabine or high-dose cytarabine, pegaspargase, and combination chemotherapy followed by daunorubicin hydrochloride or doxorubicin hydrochloride is more effective in treating young patients with acute lymphoblastic leukemia. PURPOSE: This randomized phase II/III trial is studying the side effects of giving clofarabine compared with giving high-dose cytarabine, pegaspargase, and combination chemotherapy followed by daunorubicin hydrochloride or doxorubicin hydrochloride and to see how well it works in treating young patients with T-cell acute lymphoblastic leukemia or precursor B-cell acute lymphoblastic leukemia.

Timeline

Start
2010-10
Primary completion
2019-12
Completion
2024-11-20

Drugs

EvaluationDrugModalityDoseRoute
Comparator Clofarabine Other / unclassified 40 mg Intravenous
Comparator Cytarabine Small molecule 2.5 g Intravenous
Comparator Cytarabine Small molecule 3 g Intravenous
Comparator Daunorubicin Small molecule 36 mg/m2 Intravenous
Comparator Doxorubicin Other / unclassified 30 mg/m2 Intravenous
Comparator Pegaspargase Protein / enzyme biologic Intravenous
Comparator Cyclophosphamide Other / unclassified Intravenous
Comparator Dexamethasone Small molecule Oral
Comparator Etoposide Small molecule Intravenous
Comparator MERCAPTOPURINE ANHYDROUS Small molecule Oral
Comparator Methotrexate Small molecule Intravenous
Comparator Methylprednisolone Other / unclassified Intravenous
Comparator Thioguanine Small molecule Oral
Comparator Vincristine Small molecule Intravenous
Comparator amsacrine Small molecule Intravenous

Indications